.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,357,891

« Back to Dashboard

Details for Patent: 7,357,891

Title:Process for making an ingestible film
Abstract: The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity.
Inventor(s): Yang; Robert K. (Flushing, NY), Fuisz; Richard C. (McLean, VA), Myers; Gary L. (Kingsport, TN), Fuisz; Joseph M. (McLean, VA)
Assignee: MonoSol Rx, LLC (Portage, IN)
Filing Date:Jan 30, 2004
Application Number:10/768,809
Claims:1. A process for making an ingestible film having a substantially uniform distribution of components and a desired level of a pharmaceutical or biological active component, comprising the steps of: (a) combining a polymer component, water and a pharmaceutical or biological active component to form a matrix with a uniform distribution of said components; (b) forming a film from said matrix; (c) providing a conveyor surface having top and bottom sides; (d) feeding said film onto said top side of said surface; and (e) drying said film within about 10 minutes or fewer by applying hot air currents to said bottom side of said conveyor surface with substantially no hot air currents on the top side of said surface and exposing said film to a temperature above a degradation temperature of said pharmaceutical or biological active component, wherein said degradation temperature is 70.degree. C. or higher, wherein said pharmaceutical or biological active component is maintained at said desired level.

2. The process of claim 1, wherein said drying step maintains a non-self-aggregating uniform heterogeneity of said components throughout said film.

3. The process of claim 1, wherein said film is flexible when dried.

4. The process of claim 1, wherein said film is self-supporting.

5. The process of claim 1, wherein uniform distribution determines the amount of active material component per area.

6. The process of claim 1, wherein a specific amount of the active material component may be obtained from said film by cutting said film to a predetermined size.

7. A process for making an ingestible film having a substantially uniform distribution of components and a desired level of a pharmaceutical or biological active component, comprising the steps of: (a) forming a masterbatch premix of a water-soluble polymer component and water; (b) feeding a predetermined amount of said premix to at least one mixer; (c) adding a pharmaceutical or biological active component to said at least one mixer; (d) mixing said pharmaceutical or biological active component and said predetermined amount of said premix to form a matrix having a uniform distribution of components; (e) forming a film from said matrix; (f) providing a conveyor surface having top and bottom sides; (g) feeding said film onto said top side of said surface; and (h) drying said film by applying heat to said bottom side of said conveyor surface and exposing said film to a temperature above a degradation temperature of said pharmaceutical or biological active component, wherein said degradation temperature is 70.degree. C. or higher, wherein said drying step further comprises rapidly forming a visco-elastic film within about the first 4.0 minutes by applying hot air currents to said bottom side of said surface in the absence of hot air currents on the ton side of said surface; and drying said visco-elastic film to form a self-supporting ingestible film, wherein said pharmaceutical or biological active component is maintained at said desired level.

8. The process of claim 1, wherein said drying of said film reduces the weight percent of said water to about 10% or less.

9. The process of claim 7, wherein said drying of said film reduces the weight percent of said water to about 10% or less.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc